Bluelinea SA risk profile

48 Elevated one input has moved against it

Measured 1 September 2026 from ALBLU's filed statements. Recomputed nightly.

48 (Elevated), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation85AcuteStableDrawdown from the 52-week high — 72.2%
Operating pressure46ElevatedWorseningOperating-margin drift — -4.0 percentage points
Cash conversion100AcuteStableCapital spending against operating cash — -1.29x
Leverage and coverage55ElevatedEasingNet debt to EBITDA — 3.90x
Competitive position26NormalStableRevenue-growth gap against peers — -7.0 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Bluelinea SA